[1]
|
L. A. Cone, D. R. Woodard, P. M. Schlievert and G. S. Tomory, “Clinical and Bacteriologic Observations of a Toxic Shock-Like Syndrome Due to Streptococcus pyogenes,” New England Journal of Medicine, Vol. 317, No. 3, 1987, pp. 146-149.
doi:10.1056/NEJM198707163170305
|
[2]
|
C. W. Hoge, B. Schwartz, D. F. Talkington, R. F. Breiman, E. M. MacNeill and S. J. Englender, “The Changing Epidemiology of Invasive Group A Streptococcal Infections and the Emergence of Streptococcal Toxic ShockLike Syndrome. A Retrospective Population-Based Study,” JAMA, Vol. 269, No. 3, 1993, pp. 384-389.
doi:10.1001/jama.1993.03500030082037
|
[3]
|
B. Schwartz, R. R. Facklam and R. F. Breiman, “Changing Epidemiology of Group A Streptococcal Infection in the USA,” Lancet, Vol. 336, No. 8724, 1990, pp. 1167-1171. doi:10.1016/0140-6736(90)92777-F
|
[4]
|
D. L. Stevens, “Invasive Group A Streptococcal Infections: The Past, Present and Future,” Pediatric Infectious Disease Journal, Vol. 13, No. 6, 1994, pp. 561-566.
doi:10.1097/00006454-199406000-00033
|
[5]
|
M. Minami, Y. Wakimoto, M. Matsumoto, H. Matsui, Y. Kubota, A. Okada, M. Isaka, I. Tatsuno, Y. Tanaka and T. Hasegawa, “Characterization of Streptococcus pyogenes Isolated from Balanoposthitis Patients Presumably Transmitted by Penile-Oral Sexual Intercourse,” Current Microbiology, Vol. 61, No. 2, 2010, pp. 101-105.
doi:10.1007/s00284-010-9581-x
|
[6]
|
T. Hasegawa, S. N. Hashikawa, T. Nakamura, K. Torii and M. Ohta, “Factors Determining Prognosis in Streptococcal Toxic Shock-Like Syndrome: Results of a Nationwide Investigation in Japan,” Microbes and Infection, Vol. 6, No. 12, 2004, pp. 1073-1077.
doi:10.1016/j.micinf.2004.06.001
|
[7]
|
M. W. Cunningham, “Pathogenesis of Group A Streptococcal Infections,” Clinical Microbiology Revews, Vol. 13, No. 4, 2000, pp. 470-511.
doi:10.1128/CMR.13.3.470-511.2000
|
[8]
|
R. J. Olsen, S. A. Shelburne and J. M. Musser, “Molecular Mechanisms Underlying Group A Streptococcal Pathogenesis,” Cellular Microbiology, Vol. 11, No. 1, 2009, pp. 1-12. doi:10.1111/j.1462-5822.2008.01225.x
|
[9]
|
A. L. Bricker, C. Cywes, C. D. Ashbaugh and M. R. Wessels, “NAD+-Glycohydrolase Acts as an Intracellular Toxin to Enhance the Extracellular Survival of Group A Streptococci,” Molecular Microbiology, Vol. 44, No. 1, 2002, pp. 257-269.
doi:10.1046/j.1365-2958.2002.02876.x
|
[10]
|
J. C. Madden, N. Ruiz and M. Caparon, “Cytolysin-Mediated Translocation (CMT): A Functional Equivalent of Type III Secretion in Gram-Positive Bacteria,” Cell, Vol. 104, No. 1, 2001, pp. 143-152.
doi:10.1016/S0092-8674(01)00198-2
|
[11]
|
M. A. Meehl, J. S. Pinkner, P. J. Anderson, S. J. Hultgren and M. G. Caparon, “A Novel Endogenous Inhibitor of the Secreted Streptococcal NAD-Glycohydrolase,” PLoS Pathogens, Vol. 1, No. 4, 2005, p. e35.
doi:10.1371/journal.ppat.0010035
|
[12]
|
H. Kimoto, Y. Fujii, S. Hirano, Y. Yokota and A. Taketo, “Genetic and Biochemical Properties of Streptococcal NAD-Glycohydrolase Inhibitor,” Journal of Biological Chemistry, Vol. 281, No. 14, 2006, pp. 9181-9189.
doi:10.1074/jbc.M506879200
|
[13]
|
R. Lutticken, D. Lutticken, D. R. Johnson and L. W. Wannamaker, “Application of a New Method for Detecting Streptococcal Nicotinamide Adenine Dinucleotide Glycohydrolase to Various M Types of Streptoccus pyogenes,” Journal of Clinical Microbiology, Vol. 3, No. 5, 1976, pp. 533-536.
|
[14]
|
A. Michos, I. Gryllos, A. Hakansson, A. Srivastava, E. Kokkotou and M. R. Wessels, “Enhancement of Streptolysin O Activity and Intrinsic Cytotoxic Effects of the Group A Streptococcal Toxin, NAD-Glycohydrolase,” Journal of Biological Chemistry, Vol. 281, No. 12, 2006, pp. 8216-8223. doi:10.1074/jbc.M511674200
|
[15]
|
D. Ajdic, W. M. McShan, D. J. Savic, D. Gerlach and J. J. Ferretti, “The NAD-Glycohydrolase (nga) Gene of Streptococcus pyogenes,” FEMS Microbiology Letters, Vol. 191, No. 2, 2000, pp. 235-241.
doi:10.1111/j.1574-6968.2000.tb09345.x
|
[16]
|
T. Karasawa, K. Yamakawa, D. Tanaka, Y. Gyobu and S. Nakamura, “NAD(+)-Glycohydrolase Productivity of Haemolytic Streptococci Assayed by a Simple Fluorescent Method and Its Relation to T Serotype,” FEMS Microbiolgy Letters, Vol. 128, No. 3, 1995, pp. 289-292.
doi:10.1111/j.1574-6968.1995.tb07538.x
|
[17]
|
P. D. Lazarides and A. W. Bernheimer, “Association of Production of Diphosphopyridine Nucleotidase with Serological Type of Group A Streptococcus,” Journal of Bacteriology, Vol. 74, No. 3, 1957, pp. 412-413.
|
[18]
|
I. Tatsuno, J. Sawai, A. Okamoto, M. Matsumoto, M. Minami, M. Isaka, M. Ohta and T. Hasegawa, “Characterization of the NAD-Glycohydrolase in Streptococcal Strains,” Microbiology, Vol. 153, No. 12, 2007, pp. 4253-4260.
doi:10.1099/mic.0.2007/009555-0
|
[19]
|
D. J. Riddle, D. E. Bessen and M. G. Caparon, “Variation in Streptococcus pyogenes NAD+ Glycohydrolase Is Associated with Tissue Tropism,” Journal of Bacteriology, Vol. 192, No. 14, 2010, pp. 3735-3746.
doi:10.1128/JB.00234-10
|
[20]
|
I. Tatsuno, M. Isaka, M. Minami and T. Hasegawa, “NADase as a Target Molecule of in Vivo Suppression of the Toxicity in the Invasive M-1 Group A Streptococcal Isolates,” BMC Microbiology, Vol. 10, 2010, p. 144.
doi:10.1186/1471-2180-10-144
|
[21]
|
J. J. Ferretti, W. M. McShan, D. Ajdic, D. J. Savic, G. Savic, K. Lyon, C. Primeaux, S. Sezate, A. N. Suvorov, S. Kenton, H. S. Lai, S. P. Lin, Y. Qian, H. G. Jia, F. Z. Najar, Q. Ren, H. Zhu, L. Song, J. White, X. Yuan, S. W. Clifton, B. A. Roe and R. McLaughlin, “Complete Genome Sequence of an M1 Strain of Streptococcus pyogenes,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 8, 2001, pp. 4658-4663. doi:10.1073/pnas.071559398
|
[22]
|
A. N. Suvorov and J. J. Ferretti, “Physical and Genetic Chromosomal Map of an M Type 1 Strain of Streptococcus pyogenes,” Journal of Bacteriology, Vol. 178, No. 18, 1996, pp. 5546-5549.
|
[23]
|
A. Podbielski, B. Spellerberg, M. Woischnik, B. Pohl and R. Lutticken, “Novel Series of Plasmid Vectors for Gene Inactivation and Expression Analysis in Group A Streptococci (GAS),” Gene, Vol. 177, No. 1, 1996, pp. 137-147. doi:10.1016/0378-1119(96)84178-3
|
[24]
|
S. Lukomski, N. P. Hoe, I. Abdi, J. Rurangirwa, P. Kordari, M. Liu, S. J. Dou, G. G. Adams and J. M. Musser, “Nonpolar Inactivation of the Hypervariable Streptococcal Inhibitor of Complement Gene(sic) in Serotype M1 Streptococcus pyogenes Significantly Decreases Mouse Mucosal Colonization,” Infection and Immunity, Vol. 68, No. 2, 2000, pp. 535-542.
doi:10.1128/IAI.68.2.535-542.2000
|
[25]
|
C. D. Ashbaugh, H. B. Warren, V. J. Carey and M. R. Wessels MR, “Molecular Analysis of the Role of the Group A Streptococcal Cysteine Protease, Hyaluronic Acid Capsule, and M Protein in a Murine Model of Human Invasive Soft-Tissue Infection,” Journal of Clinical Investigation, Vol. 102, No. 3, 1998, pp. 550-560.
doi:10.1172/JCI3065
|
[26]
|
N. Okada, I. Tatsuno, E. Hanski, M. Caparon and Sasakawa C, “Streptococcus pyogenes Protein F Promotes Invasion of HeLa Cells,” Microbiology, Vol. 144, No. 11, 1998, pp. 3079-3086.
doi:10.1099/00221287-144-11-3079
|